142 related articles for article (PubMed ID: 21723058)
1. Multiple cavitations in posterior reversible leukoencephalopathy syndrome associated with hemolytic-uremic syndrome.
Fujii K; Matsuo K; Takatani T; Uchikawa H; Kohno Y
Brain Dev; 2012 Apr; 34(4):318-21. PubMed ID: 21723058
[TBL] [Abstract][Full Text] [Related]
2. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy and cerebral vasoconstriction in a patient with hemolytic uremic syndrome.
Agarwal R; Davis C; Altinok D; Serajee FJ
Pediatr Neurol; 2014 May; 50(5):518-21. PubMed ID: 24731845
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic uremic syndrome: an emerging health risk.
Razzaq S
Am Fam Physician; 2006 Sep; 74(6):991-6. PubMed ID: 17002034
[TBL] [Abstract][Full Text] [Related]
5. [Hemorrhagic colitis and hemolytic uremic syndrome caused by Escherichia coli O157:H7].
Attar A; Becheur H; Gilbert T; Bloch F; Petite JP
Ann Med Interne (Paris); 1998 Sep; 149(5):288-90. PubMed ID: 9791563
[TBL] [Abstract][Full Text] [Related]
6. Bilateral striatal necrosis in hemolytic-uremic syndrome.
Hrynchak M; Ang LC; Munoz DG
Clin Neuropathol; 1992; 11(1):45-8. PubMed ID: 1547581
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura presenting with reversible posterior leukoencephalopathy syndrome.
AOTA Y; KODAMA S; KITAGAWA N; KAWABATA S; GOTOH A; SAKURAI M
Rinsho Ketsueki; 2009 Nov; 50(11):1652-4. PubMed ID: 20009443
[TBL] [Abstract][Full Text] [Related]
8. "Children on the frontline against E. coli": typical hemolytic-uremic syndrome.
Andersen H
Clin Lab Sci; 2005; 18(2):90-9. PubMed ID: 15916241
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome associated with nephrotic syndrome.
Zhang HL; Yang Y; Wu J
Neuro Endocrinol Lett; 2010; 31(6):728; author reply 729-30. PubMed ID: 21196919
[TBL] [Abstract][Full Text] [Related]
10. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.
Raffaelli RM; Paladini M; Hanson H; Kornstein L; Agasan A; Slavinski S; Weiss D; Fennelly GJ; Flynn JT
Pediatr Infect Dis J; 2007 Oct; 26(10):951-3. PubMed ID: 17901803
[TBL] [Abstract][Full Text] [Related]
11. MRI findings of hemolytic uremic syndrome with encephalopathy: widespread symmetrical distribution.
Nakamura H; Takaba H; Inoue T; Saku Y; Saito F; Ibayashi S; Fujishima M
J Neuroimaging; 2003 Jan; 13(1):75-8. PubMed ID: 12593135
[TBL] [Abstract][Full Text] [Related]
12. [Reversible posterior leukoencephalopathy syndrome: an infrequent complication in the course of haemolytic-uremic syndrome].
Gómez-Lado C; Martinón-Torres F; Alvarez-Moreno A; Eirís-Puñal J; Carreira-Sande N; Rodriguez-Nuñez A; Castro-Gago M
Rev Neurol; 2007 Apr 16-30; 44(8):475-8. PubMed ID: 17455161
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.
Neill MA; Tarr PI; Clausen CR; Christie DL; Hickman RO
Pediatrics; 1987 Jul; 80(1):37-40. PubMed ID: 3299236
[TBL] [Abstract][Full Text] [Related]
14. [Posterior reversible encephalopathy syndrome induced by acute postinfectious glomerulonephritis].
Sfaihi L; Kamoun F; Hentati Y; Tiss O; Maaloul I; Kamoun T; Mnif Z; Hachicha M
Arch Pediatr; 2013 Jun; 20(6):633-6. PubMed ID: 23619208
[TBL] [Abstract][Full Text] [Related]
15. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
[TBL] [Abstract][Full Text] [Related]
16. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
[TBL] [Abstract][Full Text] [Related]
17. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
[TBL] [Abstract][Full Text] [Related]
18. [Reversible posterior leukoencephalopathy or brain tumor--case report].
Ribarić B; Milat D; Gadze ZP; Franjić J; Petravić D
Lijec Vjesn; 2010; 132(5-6):151-4. PubMed ID: 20677621
[TBL] [Abstract][Full Text] [Related]
19. Secondary sclerosing cholangitis and portal hypertension after O157 enterocolitis: Extremely rare complications of hemolytic uremic syndrome.
Urushihara N; Ariki N; Oyama T; Chouda Y; Yagi T; Inoue T; Tomiyama Y; Nishiuchi R; Oda M; Tanaka N
J Pediatr Surg; 2001 Dec; 36(12):1838-40. PubMed ID: 11733919
[TBL] [Abstract][Full Text] [Related]
20. Hemolytic uremic syndrome without hemolytic anemia: a case report.
Akashi Y; Yoshizawa N; Oshima S; Takeuchi A; Kubota T; Kondo S; Oda T; Shimizu J; Ishida A; Nakabayashi I
Clin Nephrol; 1994 Aug; 42(2):90-4. PubMed ID: 7955584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
